Perineural invasion as a predictor of PSA outcome following local therapy for patients with clinically localized prostate cancer.
D'Amico
A V
AV
Brigham and Women's Hospital and Dana Farber Cancer Institute, Department of Radiation Oncology, Boston, Massachusetts 02115, USA.
D000230:Adenocarcinoma / Q000473:pathology* / Q000532:radiotherapy; D001707:Biopsy, Needle / Q000379:methods; D001918:Brachytherapy / Q000379:methods; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D009361:Neoplasm Invasiveness; D010524:Peripheral Nervous System Neoplasms / Q000473:pathology* / Q000628:therapy; D017430:Prostate-Specific Antigen / Q000032:analysis; D011471:Prostatic Neoplasms / Q000473:pathology* / Q000532:radiotherapy
D017430:Prostate-Specific Antigen